PVmed is a medical image analysis platform based on artificial intelligence. It researches and develops imaging detection technology for breast cancer and carcinoma nasopharyngeal using big data technology to improve its detection rate. The company was founded in 2017 and is based in Guangzhou, China.
PVmed's Product Videos
PVmed's Products & Differentiators
Intelligent Radiotherapy Solution
Expert Collections containing PVmed
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
PVmed is included in 4 Expert Collections, including Artificial Intelligence.
Companies developing artificial intelligence solutions, including cross-industry applications, industry-specific products, and AI infrastructure solutions.
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
Women's Health Tech
This collection includes companies applying technology to address a spectrum of physical, mental, and social well-being concerns specific to women. Examples include companies in reproductive health, maternal care, fertility tracking, and menopause support.
This collection includes companies applying technology to cancer care, diagnosis, and treatment. Examples include vendors offering cancer detection and diagnosis, oncology clinical decision support, real-world data, and AI oncology drug discovery.
Latest PVmed News
Dec 23, 2022
PVmed Guangzhou China based global artificial intelligence cancer treatment company secures USD 14M (RM100M)Series A funding
PVmed Frequently Asked Questions (FAQ)
When was PVmed founded?
PVmed was founded in 2017.
Where is PVmed's headquarters?
PVmed's headquarters is located at Room 1312, Block B, Guangzhou.
What is PVmed's latest funding round?
PVmed's latest funding round is Series A - IV.
How much did PVmed raise?
PVmed raised a total of $29.4M.
Who are the investors of PVmed?
Investors of PVmed include JHF Investment, COCOCAPITAL, Philips, Cherami, Strategy Capital and 5 more.
Who are PVmed's competitors?
Competitors of PVmed include MVision AI and 3 more.
What products does PVmed offer?
PVmed's products include PV-iRT and 2 more.
Who are PVmed's customers?
Customers of PVmed include Philips and Nanxishan Hospital of Guangxi Zhuang Autonomous Region.
Compare PVmed to Competitors
Mirada Medical develops medical imaging software applications. It provides simple and accessible solutions to complex image analysis problems in the diagnosis and treatment of cancer and other diseases. Its products improve consistency and productivity while enabling clinicians to deliver more personalized care. It was founded in 2000 and is based in Oxford, United Kingdom.
Caristix is a company that focuses on healthcare IT, specifically in the domain of data flow and interoperability for hospitals and other healthcare partners. The company offers software solutions that automate tasks related to interoperability and data flow, such as scoping, testing, and maintenance, with the aim of simplifying the integration of complex IT systems in healthcare settings. The primary sectors that Caristix serves are the healthcare and IT industries. It is based in Quebec City, Quebec.
iNTERFACEWARE provides professional, customized or general consulting services to aid in the implementation of projects involving HL7 product suite.
Eversolve provides development tools to put customers in control of HL7, ASTM, and X12 message implementation: Medi7 Parser Toolkit.
Commure provides a healthcare technology platform. It helps to boost its users' clinical and financial performance with applications designed to streamline care delivery ensuring revenue integrity and also keep its users' workforce safe from violence with a discreet badge designed to call for help. Commure was formerly known as PatientKeeper. The company was founded in 2017 and is based in San Francisco, California.
Synaptiq is a company focused on leveraging artificial intelligence in the healthcare sector, specifically in the field of radiotherapy. The company's main product is a revolutionary software that uses AI to distinguish between cancerous tumors and organs at risk, significantly reducing the time required for contouring in radiotherapy. Synaptiq primarily serves the healthcare industry, with a particular emphasis on cancer treatment centers and radiation oncologists. It was founded in 2020 and is based in Cluj-Napoca, Romania.